220 likes | 355 Views
Multipurpose Prevention Technologies What are they & why do we need them?. [Presenter name, degree, affiliation] [Event title]. [Date]. Multipurpose Prevention Technologies for Reproductive Health. What do women want and need?. Every year. 80 million unintended pregnancies
E N D
Multipurpose Prevention TechnologiesWhat are they & why do we need them? [Presenter name, degree, affiliation] [Event title] [Date]
Multipurpose Prevention Technologies for Reproductive Health What do women want and need?
Every year. . . • 80 million unintended pregnancies • 358,000 women die from pregnancy- related complications • 2.5 million people infected with HIV • 340 million new gonorrhea, syphilis, trichomonas infections • 250,000 deaths from cervical cancer • 16 % (15-49) have genital herpes (HSV-2)
products that… Imagine • Prevent pregnancy, HIV/AIDS & STIs at the same time • Ensure women’s privacy and safety • Are affordable & easily available • Are designed by women for their specific needs & preferences
50 years of contraceptive advances Sheldon Segal First long term drug delivery device Norplant
;Female-controlled MPTs Female Condom SILCS Diaphragm Women’s Condom
Currently available MPTs Female Condom Male Condom
Emerging MPTs Drug combinations Multipurpose vaccines Drug/device combinations Bacterial therapeutics Nanoparticals
Potential Delivery Mechanisms for MPTs • Devices • SILCS Diaphragm • Women’s Condom • Vaginal Rings • Drug release rates differ by ring type • Matrix rings vs. Reservoir rings • Release rates differ in-vitro from in-vivo • Vaginal Tablet • Combining different class ART • Vaginal Film • Nontoxic to cells and flora, fast dissolution
Multipurpose Vaccines: the future • Today: Single purpose vaccines (HPV & HBV) are commercially available • Next 2 decades: Dual-purpose vaccines that prevent transmission of HSV, HIV, Gonorrhea, Chlamydia, Trichomonas or other STIs • Contraceptive vaccines not likely
MPTs in the Pipeline Mapping Matrix: www.cami-health.org
CAMI Activities • MPT Think Tank (May 2011) • Target Product Profile working groups (May – Oct 2011) • ARHP Conference (September 2011) • APHA Conference (October 2011) • International MPT Symposium, DC (November 2011) • International MPT Symposium, London (January 2012) • Microbicides 2012 Conference, Sydney (April 2012) • NEXT STEPS
Future directions and priorities • Support and coordinate novel approaches for multi-disciplinary collaboration • Facilitate funding for research & development • Expand global and US support • Refine priority Product Profiles • Assist with clarifying the regulatory pathways
Questions? • www.cami-health.org • www.arhp.org • www.phi.org